{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T09:43:30Z","timestamp":1784886210212,"version":"3.55.0"},"reference-count":85,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T00:00:00Z","timestamp":1599696000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"SPOR Evidence Alliance"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0238844","type":"journal-article","created":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T17:28:20Z","timestamp":1599758900000},"page":"e0238844","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Antenatal and postpartum prevention of Rh alloimmunization: A systematic review and GRADE analysis"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5871-2137","authenticated-orcid":true,"given":"Candyce","family":"Hamel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Esmaeilisaraji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micere","family":"Thuku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Michaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9715-8634","authenticated-orcid":true,"given":"Lindsey","family":"Sikora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Fung-Kee-Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,9,10]]},"reference":[{"key":"pone.0238844.ref001","doi-asserted-by":"crossref","first-page":"227.e1","DOI":"10.1016\/j.ajog.2019.05.019","article-title":"The continuing burden of Rh disease 50 years after the introduction of anti-Rh(D) immunoglobin prophylaxis: call to action","volume":"221","author":"GHA Visser","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"pone.0238844.ref002","doi-asserted-by":"crossref","first-page":"S207","DOI":"10.1016\/j.jogc.2019.08.038","article-title":"From Tragedy to Triumph: Canadian Connections in the Management of Rhesus Hemolytic Disease of the Newborn","volume":"41","author":"TF Baskett","year":"2019","journal-title":"J Obstet Gynaecol Can"},{"key":"pone.0238844.ref003","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1056\/NEJM197505082921906","article-title":"Prevention of Rh hemolytic disease\u2014ten years\u2019 clinical experience with Rh immune globulin","volume":"292","author":"VJ Freda","year":"1975","journal-title":"N Engl J Med"},{"key":"pone.0238844.ref004","first-page":"623","article-title":"Rh isoimmunization during pregnancy: antenatal prophylaxis","volume":"118","author":"JM Bowman","year":"1978","journal-title":"Can Med Assoc J"},{"key":"pone.0238844.ref005","first-page":"65","article-title":"Use of evidence for clinical practice guideline development","volume":"7","author":"S Bhaumik","year":"2017","journal-title":"Trop Parasitol"},{"key":"pone.0238844.ref006","article-title":"Anti-D administration after spontaneous miscarriage for preventing Rhesus alloimmunisation","author":"L Karanth","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"pone.0238844.ref007","article-title":"Anti-D administration in pregnancy for preventing Rhesus alloimmunisation","author":"RD McBain","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"pone.0238844.ref008","article-title":"Anti-D administration after childbirth for preventing Rhesus alloimmunisation","author":"C Crowther","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"pone.0238844.ref009","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1055\/s-0037-1606609","article-title":"Prevention of RhD Alloimmunization: A Comparison of Four National Guidelines","volume":"35","author":"JD Sperling","year":"2018","journal-title":"Am J Perinatol"},{"key":"pone.0238844.ref010","first-page":"765","article-title":"Prevention of Rh Alloimmunization. SOGC Clinical Practice Guidelines. No. 133","volume":"25","author":"K Fung Kee Fung","year":"2003","journal-title":"J Obstet Gynaecol Can"},{"key":"pone.0238844.ref011","doi-asserted-by":"crossref","unstructured":"ACOG. Practice Bulletin No. 181: Prevention of Rh D Alloimmunization. Obstet Gynecol 2017;130:e57. https:\/\/doi.org\/10.1097\/AOG.0000000000002232.","DOI":"10.1097\/AOG.0000000000002232"},{"key":"pone.0238844.ref012","unstructured":"RANZCOG. Guidelines for the use of Rh(D) Immunoglobulin (Anti-D) in obstetrics in Australia 2015."},{"key":"pone.0238844.ref013","unstructured":"RCOG. Gestational Trophoblastic Disease (Green-top Guideline No. 38) 2010."},{"key":"pone.0238844.ref014","unstructured":"RCOG. Rhesus D Prophylaxis, The Use of Anti-D Immunoglobulin for (Green-top Guideline No. 22) 2011."},{"key":"pone.0238844.ref015","unstructured":"RCOG. Red Cell Antibodies during Pregnancy, The Management of Women with (Green-top Guideline No. 65) 2014."},{"key":"pone.0238844.ref016","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/jrsm.1313","article-title":"Using systematic reviews in guideline development: The GRADE approach","volume":"10","author":"Y Zhang","year":"2019","journal-title":"Res Synth Methods"},{"key":"pone.0238844.ref017","doi-asserted-by":"crossref","first-page":"264W64","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"D Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"pone.0238844.ref018","doi-asserted-by":"crossref","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"BJ Shea","year":"2017","journal-title":"BMJ"},{"key":"pone.0238844.ref019","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jclinepi.2016.01.021","article-title":"PRESS Peer Review of Electronic Search Strategies: 2015 Guideline Statement","volume":"75","author":"J McGowan","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"pone.0238844.ref020","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/2046-4053-1-10","article-title":"Evidence summaries: the evolution of a rapid review approach","volume":"1","author":"S Khangura","year":"2012","journal-title":"Syst Rev"},{"key":"pone.0238844.ref021","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"JPT Higgins","year":"2011","journal-title":"BMJ"},{"key":"pone.0238844.ref022","unstructured":"Higgins, JPT, Green, S, editors. Cochrane Handbook: Chapter 8: Assessing risk of bias in included studies. Subsection 8.7: Summary assessment of risk of bias 2011."},{"key":"pone.0238844.ref023","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"JA Sterne","year":"2016","journal-title":"BMJ"},{"key":"pone.0238844.ref024","unstructured":"Review Manager (RevMan). Copenhagen, Norway: The Nordic Cochrane Centre, The Cochrane Collaboration; 2014."},{"key":"pone.0238844.ref025","doi-asserted-by":"crossref","unstructured":"Higgins J, Green S. Cochrane handbook for systematic reviews of interventions. Wiley Online Library; 2008.","DOI":"10.1002\/9780470712184"},{"key":"pone.0238844.ref026","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"JAC Sterne","year":"2011","journal-title":"BMJ"},{"key":"pone.0238844.ref027","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"D Atkins","year":"2004","journal-title":"BMJ"},{"key":"pone.0238844.ref028","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"H Balshem","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"pone.0238844.ref029","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jclinepi.2011.01.012","article-title":"GRADE guidelines 6. Rating the quality of evidence\u2014imprecision","volume":"64","author":"GH Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"pone.0238844.ref030","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/bmj.2.5762.610","article-title":"Prevention of Rh-haemolytic disease: results of the Liverpool \u201clow-risk\u201d clinical trial","volume":"2","author":"JC Woodrow","year":"1971","journal-title":"Br Med J"},{"key":"pone.0238844.ref031","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jama.205.1.71","article-title":"Rh-o (D) immune globulin (human). Evaluation in women at risk of Rh immunization","volume":"205","author":"WQ Ascari","year":"1968","journal-title":"JAMA"},{"key":"pone.0238844.ref032","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-3148.1995.tb00180.x","article-title":"Multicentre trial of antepartum low-dose anti-D immunoglobulin","volume":"5","author":"D Lee","year":"1995","journal-title":"Transfus Med Oxf Engl"},{"key":"pone.0238844.ref033","first-page":"1021","article-title":"Prevention of primary Rh immunization: first report of the Western Canadian trial, 1966\u20131968","volume":"100","author":"B Chown","year":"1969","journal-title":"Can Med Assoc J"},{"key":"pone.0238844.ref034","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1136\/bmj.2.5762.607","article-title":"Prevention of Rh-haemolytic disease: final results of the \u201chigh-risk\u201d clinical trial. A combined study from centres in England and Baltimore","volume":"2","author":"Combined Study","year":"1971","journal-title":"Br Med J"},{"key":"pone.0238844.ref035","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1136\/bmj.4.5629.477","article-title":"Prevention of rhesus immunization. A controlled clinical trial with a comparatively low dose of anti-D immunoglobulin","volume":"4","author":"C Dudok de Wit","year":"1968","journal-title":"Br Med J"},{"key":"pone.0238844.ref036","doi-asserted-by":"crossref","unstructured":"Anonymous. Births in Great Britain resulting from assisted conception, 1978\u201387. MRC Working Party on Children Conceived by In Vitro Fertilisation. BMJ 1990;300:1229\u201333.","DOI":"10.1136\/bmj.300.6734.1229"},{"key":"pone.0238844.ref037","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/0002-9378(72)90765-X","article-title":"Do Rh-negative women with an early spontaneous abortion need Rh immune prophylaxis?","volume":"113","author":"RD Visscher","year":"1972","journal-title":"Am J Obstet Gynecol"},{"key":"pone.0238844.ref038","first-page":"341","article-title":"Rho (D) immune prophylaxis. A double-blind cooperative study","volume":"36","author":"CA White","year":"1970","journal-title":"Obstet Gynecol"},{"key":"pone.0238844.ref039","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/00006250-197803000-00013","article-title":"Reduced dose of Rh immunoglobulin following first trimester pregnancy termination","volume":"51","author":"FH Stewart","year":"1978","journal-title":"Obstet Gynecol"},{"key":"pone.0238844.ref040","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/bmj.2.5910.75","article-title":"Controlled trial of various anti-D dosages in suppression of Rh sensitization following pregnancy. Report to the Medical Research Council by the working party on the use of anti-D-immunoglobulin for the prevention of isoimmunization of Rh-negative women during pregnancy","volume":"2","author":"Medical Research Council","year":"1974","journal-title":"Br Med J"},{"key":"pone.0238844.ref041","first-page":"101","article-title":"Ante-partum administration of preventive treatment of Rh-D immunization in rhesus-negative women. Parallel evaluation of transplacental passage of fetal blood cells. Results of a multicenter study carried out in the Paris region","volume":"16","author":"J Huchet","year":"1987","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"pone.0238844.ref042","doi-asserted-by":"crossref","first-page":"261","DOI":"10.5694\/mja2.50266","article-title":"Single dose v two\u2010dose antenatal anti\u2010D prophylaxis: a randomised controlled trial","volume":"211","author":"SW White","year":"2019","journal-title":"Med J Aust"},{"key":"pone.0238844.ref043","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1046\/j.1471-0528.2003.02158.x","article-title":"Pharmacokinetics of anti-D IgG in pregnant RhD-negative women","volume":"110","author":"J Bichler","year":"2003","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"pone.0238844.ref044","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejogrb.2004.03.009","article-title":"Efficacy and safety of a new, chromatographically purified rhesus (D) immunoglobulin","volume":"117","author":"IZ MacKenzie","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"pone.0238844.ref045","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0140-6736(69)90053-1","article-title":"Use of different doses of anti-Rh IgG in the prevention of Rh isoimmunisation","volume":"2","author":"DI Buchanan","year":"1969","journal-title":"Lancet Lond Engl"},{"key":"pone.0238844.ref046","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1136\/bmj.4.5629.479","article-title":"Significance of Rh-sensitization during pregnancy: its relation to a preventive programme","volume":"4","author":"JC Godel","year":"1968","journal-title":"Br Med J"},{"key":"pone.0238844.ref047","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0140-6736(65)90321-1","article-title":"PREVENTION OF RHESUS HAEMOLYTIC DISEASE","volume":"2","author":"CA Clarke","year":"1965","journal-title":"Lancet Lond Engl"},{"key":"pone.0238844.ref048","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/oxfordjournals.bmb.a070589","article-title":"Prophylaxis of Rhesus Iso-Immunization","volume":"24","author":"C.A. Clarke","year":"1968","journal-title":"Br Med Bull"},{"key":"pone.0238844.ref049","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1537-2995.1968.tb04893.x","article-title":"Liverpool experience with Rh immunoglobulin","volume":"8","author":"R Finn","year":"1968","journal-title":"Transfusion (Paris)"},{"key":"pone.0238844.ref050","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1136\/bmj.1.5430.279","article-title":"PREVENTION OF RH-HAEMOLYTIC DISEASE: A THIRD REPORT","volume":"1","author":"JC Woodrow","year":"1965","journal-title":"Br Med J"},{"key":"pone.0238844.ref051","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1136\/bmj.2.5519.907","article-title":"Prevention of Rh-haemolytic disease: results of the clinical trial. A combined study from centres in England and Baltimore","volume":"2","year":"1966","journal-title":"Br Med J"},{"key":"pone.0238844.ref052","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1136\/bmj.1.5641.399","article-title":"Incidence of maternal Rh immunization by ABO compatible and incompatible pregnancies","volume":"1","author":"WQ Ascari","year":"1969","journal-title":"Br Med J"},{"key":"pone.0238844.ref053","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.5694\/j.1326-5377.1968.tb29206.x","article-title":"Clinical trial of one millilitre injections of RH0 (D) immune globulin (human) in the prevention of Rh immunization: preliminary report","volume":"1","author":"GJ Bishop","year":"1968","journal-title":"Med J Aust"},{"key":"pone.0238844.ref054","doi-asserted-by":"crossref","first-page":"171","DOI":"10.5694\/j.1326-5377.1969.tb105689.x","article-title":"One millilitre injections of Rh (D) immune globulin (human) in prevention of Rh immunization. A further report on the clinical trial","volume":"2","author":"GJ Bishop","year":"1969","journal-title":"Med J Aust"},{"key":"pone.0238844.ref055","first-page":"82","article-title":"Clinical evaluation of Rho(D) immune globulin (human) in Canada","volume":"101","author":"EC Bryant","year":"1969","journal-title":"Can Med Assoc J"},{"key":"pone.0238844.ref056","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1126\/science.151.3712.828","article-title":"Rh factor: prevention of isoimmunization and clinical trial on mothers","volume":"151","author":"VJ Freda","year":"1966","journal-title":"Science"},{"key":"pone.0238844.ref057","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jama.1967.03120060088014","article-title":"Prevention of Rh isoimmunization. Progress report of the clinical trial in mothers","volume":"199","author":"VJ Freda","year":"1967","journal-title":"JAMA"},{"key":"pone.0238844.ref058","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1537-2995.1968.tb04892.x","article-title":"Long Beach (California) experience with Rh immunoglobulin","volume":"8","author":"ER Jennings","year":"1968","journal-title":"Transfusion (Paris)"},{"key":"pone.0238844.ref059","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1537-2995.1968.tb04895.x","article-title":"Results of clinical trials of RhoGAM in women","volume":"8","author":"W Pollack","year":"1968","journal-title":"Transfusion (Paris)"},{"key":"pone.0238844.ref060","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1537-2995.1968.tb04894.x","article-title":"Edinburgh (Scotland) experience with Rh immunoglobulin","volume":"8","author":"JG Robertson","year":"1968","journal-title":"Transfusion (Paris)"},{"key":"pone.0238844.ref061","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1471-0528.1969.tb05829.x","article-title":"A clinical trial of anti-Rho(D) immunoglobulin in the prevention of Rho(D) immunization","volume":"76","author":"JG Robertson","year":"1969","journal-title":"J Obstet Gynaecol Br Commonw"},{"key":"pone.0238844.ref062","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/0002-9378(70)90286-3","article-title":"Rho(D) immune globulin: a double blind clinical trial","volume":"106","author":"MA Stenchever","year":"1970","journal-title":"Am J Obstet Gynecol"},{"key":"pone.0238844.ref063","first-page":"232","article-title":"Current problems in prophylactic treatment of Rh-erythroblastosis","volume":"6","year":"1971","journal-title":"J Reprod Med"},{"key":"pone.0238844.ref064","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1471-0528.1999.tb08304.x","article-title":"Routine antenatal Rhesus D immunoglobulin prophylaxis: the results of a prospective 10 year study","volume":"106","author":"IZ MacKenzie","year":"1999","journal-title":"Br J Obstet Gynaecol"},{"key":"pone.0238844.ref065","first-page":"627","article-title":"Antenatal prophylaxis of Rh isoimmunization: 28-weeks\u2019-gestation service program","volume":"118","author":"JM Bowman","year":"1978","journal-title":"Can Med Assoc J"},{"key":"pone.0238844.ref066","first-page":"1","article-title":"An assessment of the hazards of amniocentesis. Report to the Medical Research Council by their Working Party on Amniocentesis","volume":"85","year":"1978","journal-title":"Br J Obstet Gynaecol"},{"key":"pone.0238844.ref067","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0140-6736(83)90232-5","article-title":"The Yorkshire antenatal anti-D immunoglobulin trial in primigravidae","volume":"2","author":"LA Tovey","year":"1983","journal-title":"Lancet Lond Engl"},{"key":"pone.0238844.ref068","doi-asserted-by":"crossref","first-page":"e70984","DOI":"10.1371\/journal.pone.0070984","article-title":"Targeted routine antenatal anti-D prophylaxis in the prevention of RhD immunisation\u2014outcome of a new antenatal screening and prevention program","volume":"8","author":"E Tiblad","year":"2013","journal-title":"PloS One"},{"key":"pone.0238844.ref069","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/00016348909087688","article-title":"Prenatal Rh-immune prophylaxis with 300 micrograms immune globulin anti-D in the 28th week of pregnancy","volume":"68","author":"B Trolle","year":"1989","journal-title":"Acta Obstet Gynecol Scand"},{"key":"pone.0238844.ref070","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1136\/bmj.298.6689.1671","article-title":"Efficacy and long term effects of antenatal prophylaxis with anti-D immunoglobulin","volume":"298","author":"JG Thornton","year":"1989","journal-title":"BMJ"},{"key":"pone.0238844.ref071","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1471-0528.1991.tb13427.x","article-title":"Controlling Rh haemolytic disease of the newborn in India","volume":"98","author":"KS Joseph","year":"1991","journal-title":"Br J Obstet Gynaecol"},{"key":"pone.0238844.ref072","unstructured":"Fertility rate, total (births per woman)\u2014Canada. World Bank 2019. https:\/\/data.worldbank.org\/indicator\/SP.DYN.TFRT.IN?locations=CA (accessed June 17, 2020)."},{"key":"pone.0238844.ref073","first-page":"749","article-title":"Transplacental fetal hemorrhage after amniocentesis","volume":"66","author":"JM Bowman","year":"1985","journal-title":"Obstet Gynecol"},{"key":"pone.0238844.ref074","doi-asserted-by":"crossref","first-page":"A70","DOI":"10.1186\/1745-6215-12-S1-A70","article-title":"The COMET (Core Outcome Measures in Effectiveness Trials) Initiative","volume":"12","author":"PR Williamson","year":"2011","journal-title":"Trials"},{"key":"pone.0238844.ref075","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1745-6215-8-39","article-title":"Standardising outcomes for clinical trials and systematic reviews","volume":"8","author":"M Clarke","year":"2007","journal-title":"Trials"},{"key":"pone.0238844.ref076","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1258\/jhsrp.2011.011131","article-title":"Driving up the Quality and Relevance of Research Through the Use of Agreed Core Outcomes","volume":"17","author":"P Williamson","year":"2012","journal-title":"J Health Serv Res Policy"},{"key":"pone.0238844.ref077","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1007\/s10067-019-04666-3","article-title":"Meta-analysis in the era of big data","volume":"38","author":"L Silva-Fern\u00e1ndez","year":"2019","journal-title":"Clin Rheumatol"},{"key":"pone.0238844.ref078","first-page":"112533","article-title":"Values, challenges and future directions of big data analytics in healthcare: A systematic review","volume":"241","author":"P Galetsi","year":"2019","journal-title":"Soc Sci Med 1982"},{"key":"pone.0238844.ref079","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"335","author":"E von Elm","year":"2007","journal-title":"BMJ"},{"key":"pone.0238844.ref080","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/aogs.13191","article-title":"Targeted antenatal anti-D prophylaxis program for RhD-negative pregnant women\u2014outcome of the first two years of a national program in Finland","volume":"96","author":"K Haimila","year":"2017","journal-title":"Acta Obstet Gynecol Scand"},{"key":"pone.0238844.ref081","article-title":"Sensitivity of fetal RHD screening for safe guidance of targeted anti-D immunoglobulin prophylaxis: prospective cohort study of a nationwide programme in the Netherlands","volume":"355","author":"M de Haas","year":"2016","journal-title":"BMJ"},{"key":"pone.0238844.ref082","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/pd.5176","article-title":"Noninvasive fetal RHD genotyping of RhD negative pregnant women for targeted anti-D therapy in Australia: A cost-effectiveness analysis","volume":"37","author":"LG Gordon","year":"2017","journal-title":"Prenat Diagn"},{"key":"pone.0238844.ref083","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1186\/s12884-018-2114-5","article-title":"Effectiveness and costs of non-invasive foetal RHD genotyping in rhesus-D negative mothers: a French multicentric two-arm study of 850 women","volume":"18","author":"M Darlington","year":"2018","journal-title":"BMC Pregnancy Childbirth"},{"key":"pone.0238844.ref084","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/uog.14723","article-title":"Costs and benefits of non-invasive fetal RhD determination","volume":"45","author":"L Teitelbaum","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"pone.0238844.ref085","unstructured":"Institute of Medicine (US) Committee on Standards for Developing Trustworthy Clinical Practice Guidelines. Clinical Practice Guidelines We Can Trust. Washington (DC): National Academies Press (US); 2011."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0238844","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T17:28:51Z","timestamp":1599758931000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0238844"}},"subtitle":[],"editor":[{"given":"Georg M.","family":"Schm\u00f6lzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,9,10]]},"references-count":85,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0238844","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,10]]}}}